Kuros Bioscience Ltd./ CH0325814116 /
07.06.2024 15:30:45 | Diff. +1,0000 | Volumen | Geld- | Brief- | Marktkapitalisierung | Dividendenr. | KGV |
---|---|---|---|---|---|---|---|
11,0300USD | +9,97% | 2.100 Umsatz: 22.630 |
-Geld Vol: - | -Brief Vol: - | 463,14 Mio.USD | - | - |
GlobeNewswire
11:00
Rhino Health to Deliver Enterprise Federated Computing Solutions in Collaboration With NVIDIA
GlobeNewswire
11:00
VEON and Kyivstar increase Ukraine investment commitment to USD 1 billion, attend Ukraine Recovery C...
GlobeNewswire
11:00
Oculis Announces Positive Topline Results of Phase 2b RELIEF Trial with Licaminlimab, Designed to Tr...
GlobeNewswire
10:00
Master the Complexities of International Mergers & Acquisitions with IBFD's New Online Course!
GlobeNewswire
10:00
SiSaf’s Bio-Courier Technology Enables Clinical Trial Success for Topical Treatment of Mild to Moder...
GlobeNewswire
10:00
SHCR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sharecare Inc. Investors with ...
GlobeNewswire
10:00
INTC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Intel Corporation Investors wi...
GlobeNewswire
10:00
VFS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that VinFast Auto Ltd. (f/k/a Black ...
GlobeNewswire
10:00
GDRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that GoodRx Holdings, Inc. Investor...
- Erste Seite
- Zurück
- 1
- 2
- 3
- 4
- Weiter
- Letzte Seite